Results 111 to 120 of about 1,118 (165)

Budd-Chiari syndrome: Prognostic scores, special populations, and management challenges. [PDF]

World J Gastroenterol
Elshaer M, Hafez MM, Ramadan AG, Shedeed K, Tawheed A.   +4 more
europepmc   +1 more source

Effects of organic fertilizer proportion on the distribution of soil aggregates and their associated organic carbon in a field mulched with gravel. [PDF]

Sci Rep, 2022
Du S, Ma Z, Chen J, Xue L, Tang C, Shareef TME, Siddique KHM.   +6 more
europepmc   +1 more source

Vonoprazan and proton pump inhibitors: Which is superior for <i>Helicobacter pylori</i> eradication? [PDF]

World J Gastroenterol
Ozercan M, Tawheed A, Ismail A, Amer MS, El-Kassas M.   +4 more
europepmc   +1 more source

Combination of Host-Associated Rummeliibacillus sp. and Microbacterium sp. Positively Modulated the Growth, Feed Utilization, and Intestinal Microbial Population of Olive Flounder (Paralichthys olivaceus). [PDF]

Biology (Basel), 2023
Lee SJ, Kim SH, Noh DI, Lee YS, Kim TR, Hasan MT, Lee EW, Jang WJ.   +7 more
europepmc   +1 more source

Strategies for achieving successful cannulation in endoscopic retrograde cholangiopancreatography: A technical overview. [PDF]

World J Gastrointest Endosc
Ismail A, Abdelwahab MM, Ozercan M, Elnahas O, Bahcecioglu IH, Yalniz M, Tawheed A.   +6 more
europepmc   +1 more source

Correction: Clinical and endoscopic characteristics of patients undergoing gastrointestinal endoscopic procedures in Egypt: a nationwide multicenter study. [PDF]

BMC Gastroenterol
Elbadry M, El-Raey F, Alboraie M, Abdel-Samiee M, Abdeltawab D, Ahmed MH, Sherief AF, Eliwa A, Tharwat M, Abdelmawgod A, Ahmed OA, Abdelsameea E, Mahros A, Moussa AM, Eid A, Raafat K, Yousef A, Rafea SAS, Alazzaq Y, Mare'y M, Abdelaziz A, Ibrahim ESA, El Dayem WAA, Abdelmoati AA, Tawheed A, Amer M, Zaky S, El-Kassas M.   +27 more
europepmc   +1 more source

Frugal Innovations in Orthopaedics. [PDF]

Curr Rev Musculoskelet Med
Kakulamarri S, Wahle CF, Smith L, Sabharwal S.   +3 more
europepmc   +1 more source

Tyrosine kinase inhibitors were well-tolerated among patients with different etiologies of advanced HCC with lower survival in non-viral patients. [PDF]

Sci Rep
Barakat EMF, Kohla M, Dabees H, Shousha HI, Moustafa EF, El-Kassas M, Aziz MS, Elkhateeb E, Abdelaziz AO, Abdelmalek MO, Azmy A, Tawheed A, Aboganob WM, Taha H, Lithy R, Radwan A, Ghoraba D, Sayed H, Nassief A, Elhelbawy M, Nabeel MM, Medhat MA, Askar SR, Marwan E, Rewisha E, Elbaz T, Ahmed SH, Elfouly NF, Abdeen N, Abdelmaksoud AH, Abdeltawab AA, Shamkh MAA, Ramadan A, Abdelrazek YA, Bassam M, Sayed SA, Hussein RS, Alrajhi A, Allam AE, Seyam OA, Said M.   +40 more
europepmc   +1 more source

Atezolizumab and bevacizumab combination in advanced hepatocellular carcinoma patients: The imperative for safety assessment studies.

World J Clin Cases
Tharwat M, Tawheed A, El-Kassas M.
europepmc   +1 more source

Glucagon-like peptide-1 receptor agonists: Evolution, gastrointestinal adverse effects, and future directions. [PDF]

World J Gastrointest Pharmacol Ther
Ismail A, Amer MS, Tawheed A.
europepmc   +1 more source